Clinical Trials on Fungal Infections

Total 56618 results

Mahidol University

Completed

Topical Amphotericin B in 30% Dimethylsulphoxide in Treating of Non-dermatophytes Onychomycosis (amphotericin)

Fungal Infection | Onychomycosis | Fungus, Nail

Thailand
University Hospital, Strasbourg, France

Unknown

Fungal Infection on a Joint Prosthesis

Fongal Infection
National Cancer Institute (NCI)

Completed

Surveillance of Fungal Infections in Bone Marrow/Stem Cell and Organ Transplant Recipients

Fungus Disease

United States
Blueberry Therapeutics
IQVIA Biotech

Completed

A Trial Involving Treatment of BB2603 in Subjects With Distal Subungual Onychomycosis of the Toenail

Fungal Infection | Distal Subungual Onychomycosis | Fungus, Nail

Poland, Germany, Czechia
Radboud University Medical Center

Completed

Pharmacokinetics of Micafungin in Patients Intensive Care Unit (MIMIC)

Invasive Fungal Infection

Netherlands
People's Hospital of Zhengzhou University

Completed

An Individualized Administration Research of Voriconazole Based on CYP2C19 Gene Polymorphism and TDM

Invasive Fungal Infection

China
Grupo de Estudio de Infecciones en Transplantados
Merck Sharp & Dohme LLC

Unknown

Prophylaxis With Caspofungin in High-Risk Liver Transplantation

Liver Transplantation | Fungal Infection

Spain
People's Hospital of Zhengzhou University

Recruiting

Factors on Therapeutic Drug Monitoring and Safety of Voriconazole in Critically Ill Elderly Patients

Invasive Fungal Infection

China
Nantes University Hospital

Completed

Antifungal Prophylaxis With Micafungin After Cord Blood Allogeneic Stem Cell Transplantation (MycaCOORD) (MycaCOORD)

Invasive Fungal Infection

France
University of Pittsburgh
Schering-Plough

Terminated

Limited Access Protocol of Posaconazole in Invasive Fungal Infections Study PO2095

Fungal Infection

United States
Astellas Pharma Global Development, Inc.

Completed

Registry of Patients Treated With Systemic Mold-Active Triazoles

Invasive Fungal Infection

United States
Asan Medical Center

Withdrawn

Voriconazole Plasma Level in Intensive Care Unit (ICU) Patients

Invasive Fungal Infection

Korea, Republic of
Merck Sharp & Dohme LLC

Recruiting

Posaconazole (MK-5592) Intravenous and Oral in Children (<2 Years) With Invasive Fungal Infection (MK-5592-127)

Invasive Fungal Infection

Israel, United States, Belgium, Greece, Peru, Poland, Mexico, Russian Federation
Merck Sharp & Dohme LLC

Completed

Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520)

Fungal Infection
University of Pittsburgh
Astellas Pharma US, Inc.

Completed

Invasive Fungal Infections Surveillance Initiative

Fungal Infection

United States
Ruijin Hospital
Merck Sharp & Dohme LLC

Unknown

Investigation of Clinical Relevance of β-D-Glucan Tests in Patients With Invasive Fungal Infection (IFI)

Fungal Infection
Bayside Health
Merck Sharp & Dohme LLC

Unknown

Universal Prophylaxis Versus Pre-emptive Therapy With Posaconazole Post-Lung Transplant (UPPRITE)

Fungal Infection

Australia
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Unknown

Pharmacokinetics and Pharmacodynamics of Caspofungin (Cancidas ®) and Drug Tolerance of Fungi to Patients With an Invasive Fungal Infection in the Intensive Care Unit

Invasive Fungal Infection
Southeast University, China

Completed

The PK/PD of Deoxycholic Acid Amphotericin B in Invasive Fungal Infection Patients With Sepsis/Septic Shock

Fungal Infection

China
Merck Sharp & Dohme LLC

Completed

Pharmacokinetics and Safety of Intravenous Posaconazole (MK-5592) in Chinese Participants at High Risk for Invasive Fungal Infections (MK-5592-120)

Fungal Infection

China
Merck Sharp & Dohme LLC

Completed

Pharmacokinetics and Safety of Oral Posaconazole (MK-5592)Tablets in Chinese Participants at High Risk for Invasive Fungal Infections (MK-5592-117)

Fungal Infection
Merck Sharp & Dohme LLC

Completed

Posaconazole Treatment of Invasive Fungal Infection (IFI) (P05551)

Fungal Infection
University of Cologne
Pfizer; F2G Biotech GmbH; Basilea Pharmaceutica; Cidara Therapeutics Inc.; Matinas...

Recruiting

FungiScope - A Global Emerging Fungal Infection Registry (FungiScope)

Invasive Fungal Disease

Germany
Daping Hospital and the Research Institute of Surgery...

Recruiting

Association of Plasma Transfusions and Invasive Fungal Infection (PT)

Invasive Fungal Infection | Neonatal Infection | Plasma Administration

China
Radboud University Medical Center

Completed

Pharmacokinetics of Caspofungin (Cancidas ®) Given Intravenously as Therapy to Patients With an Invasive Fungal Infection in the Intensive Care Unit - a Search for Co-variates (CASCADE)

Invasive Fungal Infection

Netherlands
Astellas Pharma Inc
Basilea Pharmaceutica International Ltd

Completed

Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis

Aspergillosis | Invasive Fungal Infection

Korea, Republic of, Belgium, Australia, United States, Germany, Switzerland, Israel, Canada, Argentina, Chile, Malaysia, Thailand, France, Russian Federation, Hungary, Spain, Brazil, China, India, Egypt, Italy, Turkey, Netherlands, Me... and more
Merck Sharp & Dohme LLC

Completed

Historical Control Study of Refractory IFI or Patients Intolerant to Standard Antifungal Therapy in Patients With Invasive Fungal Infections (Study P02387)

Infection, Invasive Fungal
Basilea Pharmaceutica

Completed

A Drug-Drug Interaction Study of CYP3A4 Inhibition and Pan-CYP Induction on APX001

Fungal Infection

Netherlands
University of Maryland, Baltimore

Completed

Itraconazole Oral Absorption

Fungal Infection

United States
Pfizer

Completed

Vfend Special Investigation For Prophylaxis

Fungal Infection
Children's Hospital Medical Center, Cincinnati
Astellas Pharma Inc

Completed

Alternate Day Micafungin: A PK Study in Pediatric Patients

Fungal Infection

United States
Children's Hospital of Philadelphia
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Fluconazole Pharmacokinetics in Infants

Fungal Infection

United States
Pfizer
Mclean Hospital

Completed

Assessment of Voriconazole Penetration Into the Brain by Fluorine-Magnetic Resonance Spectroscopy

Fungal Infection
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Immunomonitoring of Mold Invasive Infections (IMMUNOFIL)

Invasive Fungal Disease

France
University Medical Center Groningen
Pfizer

Completed

Effect of Inflammation on Voriconazole Concentration

Inflammation | Fungal Infection

Netherlands
University Hospital, Montpellier

Completed

Emerging Invasive Fungal Infections in Critically Ill Patients (EIFI)

Fungal Infection | ICU Acquired Weakness

France
Kirby Institute

Not yet recruiting

PATH Study: People With Injecting Related Infections: Assessing Treatment Outcomes for Those Who Are Hospitalised. (PATH)

Invasive Fungal Infections | Infection, Bacterial | Infection, Fungal | Injection Site Infection | Infection, Soft Tissue | Invasive Bacterial Infection
Basilea Pharmaceutica

Completed

A Study to Assess the Mass Balance Recovery and Metabolite Profile & Identification of [14C]-APX001 in Healthy Males

Fungal Infection

United Kingdom
National Institute of Allergy and Infectious Diseases...

Terminated

Safety and Pharmacokinetics of Rezafungin

Fungal Infection

United States
Merck Sharp & Dohme LLC

Terminated

A Pharmacokinetic Analysis of Posaconazole in Lung Transplant Recipients (MK-5592-105) (PAPAL)

Fungal Infection
Radboud University Medical Center

Recruiting

Pharmacokinetics of Fluconazole in Children (2-18 Years) (FOCUS)

Invasive Fungal Infections

Netherlands
Mayo Clinic

Recruiting

The Role Of Interferon-gamma In Immune Responses To Invasive Candidiasis

Candidiasis | Fungal Infection

United States
Merck Sharp & Dohme LLC

Completed

A Study of Caspofungin Acetate (MK0991) for the Treatment of Esophageal Candidiasis or Invasive Candidiasis in Chinese Adults (MK-0991-066)

Fungal Infection
Islamia University of Bahawalpur

Completed

Molecular Characterization of Candida Auris (OC)

Oral Fungal Infection

Pakistan
Chulalongkorn University

Unknown

The Study of Voriconazole Trough Level in the First Two Weeks After Administration in King Chulalongkorn Memorial Hospital.

Fungal Infection | Voriconazole

Thailand
Zhejiang University
Guangdong Provincial People's Hospital; Shanghai General Hospital, Shanghai... and other collaborators

Completed

Efficacy of Itraconazole as Secondary Prophylaxis in Patients Undergoing Allogeneic Stem Cell Transplantation or Chemotherapy With Prior Invasive Fungal Infection

Invasive Fungal Infection

China
International Centre for Diarrhoeal Disease Research...
Centers for Disease Control and Prevention; Institute of Epidemiology, Disease...

Recruiting

Fungal Surveillance in Bangladesh

Invasive Fungal Infections

Bangladesh
Shanghai Jiao Tong University School of Medicine

Recruiting

Escalation Antifungal Prophylaxis for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Fungal Infection

China
Basilea Pharmaceutica

Completed

Safety, Pharmacokinetics, Bioavailability, Food Effect, Drug-Drug Interaction Study of APX001 Administered Orally

Fungal Infection

Netherlands
Basilea Pharmaceutica

Completed

Study to Assess Safety, Tolerability and Pharmacokinetics of APX001 Administered by Intravenous Infusion to Healthy Subjects

Fungal Infection

Netherlands

Clinical Trials on Fungal Infections

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bulgaria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations